Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saccharomyces cerevisiae and Reduced Blood Pressure

Research synthesisVery low evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects on blood pressure-related outcomes, with effect sizes ranging from small to moderate. However, none of the studies reached statistical significance, and the evidence is derived entirely from in vitro and in silico peptide analyses rather than human trials.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All studies are in vitro or in silico analyses of peptide sequences; no human trials were identified. Effects observed in laboratory settings may not translate to clinical blood pressure reduction. Many of the included studies did not report statistical significance — effect may be smaller than the predominant direction suggests. Available evidence is overwhelmingly positive, but the small number of studies and lack of human data indicate publication bias may be a concern.

Generated Jul 12, 2026
3 of 3 papers
Back to top